We previously have described a model of multiple sclerosis (MS) in which constitutive expression of murine interleukin (IL)-2 by herpes simplex virus type 1 (HSV-1) (HSV-IL-2) causes central nervous system (CNS) demyelination in different strains of mice. In the current study, we investigated whether this HSV-IL-2-induced demyelination can be blocked using recombinant viruses expressing different cytokines or by injection of plasmid DNA. We have found that coinfection of HSV-IL-2-infected mice with recombinant viruses expressing IL-12p35, IL-12p40 or IL-12p35+IL-12p40 did not block the CNS demyelination, and that coinfection with a recombinant virus expressing interferon (IFN)-g exacerbated it. In contrast, coinfection with a recombinant virus expressing IL-4 reduced demyelination, whereas coinfection of HSV-IL-2-infected mice with a recombinant HSV-1 expressing the IL-12 heterodimer (HSV-IL-12p70) blocked the CNS demyelination in a dose-dependent manner. Similarly, injection of IL-12p70 DNA blocked HSV-IL-2-induced CNS demyelination in a dose-dependent manner and injection of IL-35 DNA significantly reduced CNS demyelination. Injection of mice with IL-12p35 DNA, IL-12p40 DNA, IL-12p35+IL-12p40 DNA or IL-23 DNA did not have any effect on HSV-IL-2-induced demyelination, whereas injection of IL-27 DNA increased the severity of the CNS demyelination in the HSV-IL-2-infected mice. This study demonstrates for the first time that IL-12p70 can block HSV-IL-2-induced CNS demyelination and that IL-35 can also reduce this demyelination, whereas IFN-g and IL-27 exacerbated the demyelination in the CNS of the HSV-IL-2-infected mice. Our results suggest a potential role for IL-12p70 and IL-35 signaling in the inhibition of HSV-IL-2-induced immunopathology by preventing development of autoaggressive T cells.
INTRODUCTION
Demyelinating diseases constitute a spectrum of immunopathologic syndromes in which myelin, the fatty covering of nerve cell fibers in the brain, optic nerve and spinal cord (SC), is destroyed. 1 Although the causes and pathogenesis of demyelination are unknown, one hypothesis is that autoimmunity to antigens of the central nervous system (CNS) is triggered by environmental factors, such as viral infections, in genetically susceptible individuals, and that the activated immune response leads to myelin destruction. One of the major diseases associated with degradation of the myelin sheath is multiple sclerosis (MS). 2, 3 An early manifestation of MS is visual disturbances and optic neuropathy due to demyelination of the optic nerve. This is a common cause of visual and neurological dysfunction in young adults diagnosed with MS. [4] [5] [6] [7] [8] Thus, the occurrence of optic neuropathy can be used as a prognostic indicator early in the course of MS. [4] [5] [6] [7] [8] Epidemiological studies have implicated interleukin (IL)-2 in the pathology of MS and patients with MS have elevated levels of IL-2 in their cerebrospinal fluid and sera. [9] [10] [11] [12] IL-2-deficient mice are more resistant to experimental autoimmune encephalitis (EAE) than their heterozygote and wild-type (wt) counterparts. 13 To explore the possibility that IL-2 has a role in the pathology of MS in conjunction with viral infection, we constructed a recombinant herpes simplex virus type 1 (HSV-1) that expresses murine IL-2 constitutively, 14 as well as a panel of control recombinant viruses that express murine IL-4, interferon (IFN)-g, IL-12p35, IL-12p40 or IL-12p70. [15] [16] [17] [18] Ocular infection of different strains of mice (that is, BALB/c, C57BL/6, SJL/6 and 129SVE) with the HSV-IL-2 virus results in demyelination of the optic nerves, SCs and brains of the infected mice, as determined by histologic examination of tissues obtained at necropsy. 19, 20 The HSV-IL-2-infected mice also develop optic neuropathy as determined by changes in the visual-evoked cortical potentials. 20 Demyelination in mice is not detectable after infection with wt HSV-1 alone, HSV-IL-4 or HSV-IFN-g viruses, which are identical to HSV-IL-2, except that they express IL-4 or IFN-g instead of IL-2. 19, 20 We have previously found that both CD8 + and CD4 + T cells contribute to HSV-IL-2-induced CNS demyelination, with CD8 + T cells being the primary inducers of demyelination (manuscript in preparation). In the adoptive transfer studies, all of the transferred T cells were positive for expression of FoxP3, irrespective of their CD25 status, and depletion of FoxP3 blocked CNS demyelination by HSV-IL-2. Furthermore, we have shown previously that HSV-IL-2 induced a T H 0 response in infected mice, 19 which suggested that the presence of a T H 0 response may be a contributing factor to HSV-IL-2-induced demyelination. It is known that IL-12 favors the production of T H 1 cells through its ability to drive the differentiation of T H 0 cells into T H 1 cells, [21] [22] [23] whereas IL-4 favors a T H 2 response. 24, 25 Thus, it is possible that by manipulating the cytokine environment such that it can push the T H 0 responses toward a T H 1 and/or T H 2, demyelination may be prevented. We therefore undertook the current studies to determine whether IL-4, IFN-g, IL-12p35, IL-12p40, IL-12p70, IL-23, IL-27 or IL-35 modulate or exacerbate the CNS demyelination that occurs in mice that are infected ocularly with HSV-IL-2.
RESULTS

Demyelination in HSV-IL-2-infected mice is not blocked by coinfection with HSV-IL-4 virus
We have shown previously that ocular infection of mice with HSV-IL-2 recombinant virus induces demyelination of CNS in different strains of mice, including BALB/c and C57BL/6 mice. 20 Other investigators have reported that a recombinant HSV-1 expressing IL-4 protected rhesus monkeys 26 and mice 27, 28 from autoimmune encephalomyelitis. Thus, to determine whether HSV-IL-2-induced CNS demyelination can be blocked by IL-4, BALB/c mice were infected ocularly with equal amounts (2Â10 5 per eye) of HSV-IL-2 and HSV-IL-4, or with HSV-IL-2 or HSV-IL-4 alone. At day 14 post infection, mice were killed, and the brains, SCs and optic nerves collected, post-fixed and stained with the myelin stain, luxol fast blue (LFB). Representative photomicrographs of the LFB-stained sections are shown in Figure 1a . The results indicated that demyelination was not inhibited in the SC or optic nerves of the mice that were coinfected with HSV-IL-2 and HSV-IL-4 at a 1:1 ratio ( Figure 1a , left panels). Similarly, demyelination was also detected in brains of HSV-IL-2-infected mice (not shown). No demyelination was detected in the CNS of mice infected with HSV-IL-4 alone ( Figure 1a , right panels).
To determine whether higher levels of HSV-IL-4 were capable of affecting HSV-IL-2-induced CNS demyelination, groups of BALB/c mice were subjected to the same experimental protocol, except that they were coinfected with HSV-IL-4 at a dose (2Â10 7 plaque-forming units (PFUs) per eye) that was 100-fold higher than the dose of HSV-IL-2 (2Â10 5 PFUs per eye) used. Demyelination was not blocked in the brains, SCs or optic nerves of the mice that were coinfected with HSV-IL-2 and HSV-IL-4 at a 1:100 ratio ( Figure 1a , middle panels). Similar results were obtained when female C57BL/6 were coinfected with HSV-IL-2 and HSV-IL-4 recombinant viruses (data not shown). Collectively, these results indicate that IL-4 does not protect against IL-2-induced CNS demyelination in this mouse model.
Demyelination in HSV-IL-2-infected mice is not blocked following coinfection with HSV-IFN-c virus
The roles of IFN-g in MS remain controversial and a clinical trial of recombinant IFN-g for MS was discontinued prematurely due to worsening of disease. 29 To evaluate the effects of HSV-IFN-g on CNS demyelination induced by HSV-IL-2, BALB/c or C57BL/6 mice were infected ocularly with 2Â10 5 per eye of HSV-IL-2 and 2Â10 5 per eye of HSV-IFN-g, or HSV-IFN-g alone. At day 14 post infection, the mice were killed and the brains, SCs and optic nerves were stained with LFB. Representative photomicrographs of the stained sections of SCs and optic nerves are shown in Figure 1b . Demyelination was not inhibited in the SCs or optic nerves of the mice coinfected with the HSV-IL-2 plus HSV-IFN-g at a 1:1 ratio (Figure 1b , left panels, 1:1). Similarly, demyelination was also detected in brains of HSV-IL-2-infected mice (not shown). To determine whether higher doses of HSV-IFN-g were able to block HSV-IL-2-induced CNS demyelination, additional mice were subjected to the same experimental protocol, except that they were coinfected with 100-fold higher dose of HSV-IFN-g (2Â10 7 PFUs per eye) relative to HSV-IL-2 (2Â10 5 PFUs per eye). Demyelination was not blocked in the brains, SCs or optic nerves of the mice coinfected with a 1:100 ratio of HSV-IL-2 to HSV-IFN-g (Figure 1a , middle panels). These results suggest that HSV-IFN-g, even at a 100-fold higher dose, does not block HSV-IL-2-induced CNS demyelination in either mouse strain tested.
Demyelination in HSV-IL-2-infected mice is not blocked by coinfection with HSV-IL-12p35, HSV-IL-12p40 or HSV-IL-12p35+ HSV-IL-12p40 In preliminary studies using the HSV-1 recombinant viruses expressing murine IL-12p35 and IL-12p40 that we have constructed, 30 we observed that infection of macrophages with HSV-IL-2, but not wt HSV-1 or recombinant HSV-1 expressing IL-4 or IFN-g, altered the ratio of the IL-12p35 and IL-12p40 transcripts (unpublished observation). We therefore tested the possibility that coinfection of HSV-IL-2-infected mice with HSV-IL-12p35, HSV-IL-12p40 or HSV-IL-12p35+HSV-IL12p40 may prevent demyelination. As a control, some mice were coinfected with HSV-IL-2 and wt virus. BALB/c mice were infected with HSV-IL-2+HSV-IL-12p35, HSV-IL-2+HSV-IL12p40, HSV-IL-2+HSV-IL-12p35+HSV-IL12p40 or HSV-IL-2+wt at 2Â10 5 PFUs per eye of each virus. As shown in Figure 1c , at day 14 post infection, demyelination was observed in the SCs and optic nerves of all mice infected ocularly with HSV-IL-2+HSV-IL-12p35, HSV-IL-2+HSV-IL-12p40, HSV-IL-2+HSV-IL-12p35+HSV-IL12p40 or HSV-IL-2+wt, and similar results were obtained on analysis of the brains of the infected mice (data not shown). None of these recombinant viruses (HSV-IL-12p35, HSV-IL-12p40 or HSV-IL12p35+HSV-IL12p40) protected the mice from HSV-IL-2-induced demyelination, even when a higher dose (2Â10 7 PFUs per eye) of the recombinant viruses was used (data not shown). Moreover, multiple intraperitoneal injections of mice with the recombinant viruses did not inhibit CNS demyelination from HSV-IL-2 infection (data not shown). The biological activity characteristic of the IL-12 heterodimer cannot be detected in the absence of either subunit, 31, 32 as the individual subunits do not exhibit IL-12 heterodimer activity by themselves. 33, 34 Thus, our observation of lack of positive effect by the individual subunits is consistent with the literature. The absence of a protective effect by these recombinant viruses against HSV-IL-2-induced CNS demyelination suggests that these viruses do not promote the formation of the IL-12 heterodimer in vivo.
Demyelination in HSV-IL-2-infected mice can be blocked by coinfection with the IL-12 heterodimer in a dose-dependent manner In contrast to HSV-IL-12p35 or HSV-IL-12p40, a recombinant HSV-1 that expresses both IL-12p35 and IL-12p40 in-frame as a heterodimer (HSV-IL-12p70, also called M002) has biological activity in vivo. 18, 35 Therefore, we used an HSV-IL-12p70 recombinant virus to determine whether coinfection of mice with this virus would prevent HSV-IL-2-induced demyelination in infected mice. BALB/c mice were infected with HSV-IL-2 and HSV-IL-12p70 at a 1:1, 1:10 or 1:100 ratio, and demyelination in the optic nerves and SCs of the infected mice was evaluated on day 14 post infection. As expected, infection of the mice with HSV-IL12p70 alone did not induce demyelination ( Figure 2 , IL-12p70, right panels at 2Â10 7 PFUs per eye). Demyelination was observed in the optic nerves and SCs of all BALB/c mice infected with HSV-IL-2 and HSV-IL12p70 at a 1:1 ratio ( Figure 2 , 1:1 column, Table 1 ), whereas only one mouse showed demyelination in its SC, but not its brain or optic nerve (Table 1) . In marked contrast, none of the mice infected with a 1:100 ratio of HSV-IL-2 to HSV-IL12p70 showed any signs of demyelination ( Figure 2 , 1:100 column, Table 1 ). These results suggest that the IL-12 heterodimer can inhibit HSV-IL-2-induced CNS demyelination in ocularly infected mice in a dose-dependent manner, and high enough concentrations can block disease pathology in its entirety.
Demyelination in HSV-IL-2-infected mice can also be blocked by injection of IL-12p70 DNA To further explore the possibility that IL-12p70 can block HSV-IL-2-induced demyelination, we treated HSV-IL-2-infected mice with IL12p70 DNA. It has previously been shown that DNA vaccine-encoded immunogen is produced by dendritic cells and macrophages residing at the site of inoculation with subsequent elicitation of immune response either by directly transfected antigen-presenting cells or via cross presentation of antigen expressed from transfected somatic cells by antigen-presenting cells. 36 Role of cytokines in control of CNS demyelination M Zandian et al optic nerves, SCs and brains of infected mice were measured on day 14 post infection and the data are summarized in Table 1 . Eighty percent (four out of five) mice injected once with IL-12p70 DNA were protected from HSV-IL-2-induced CNS demyelination and similar results were obtained when the mice were injected twice and infected with HSV-IL-2 (Table 1) . Demyelination was not observed in the optic Role of cytokines in control of CNS demyelination M Zandian et al nerves, SCs or brains of the BALB/c mice that had been injected with IL-12p70 DNA three times and infected with HSV-IL-2 ( Table 1) . As expected, mice injected with vector DNA and infected with HSV-IL-2 exhibited demyelination in their optic nerves, SCs and brains (not shown). These experiments also were carried out using C57BL/6 mice and similar results were obtained (data not shown). Collectively, these results suggest that IL-12p70 DNA can inhibit HSV-IL-2-induced CNS demyelination in ocularly infected mice in a dose-dependent manner as does HSV-IL-12p70 virus.
Roles of other IL-12 family members in blocking CNS demyelination by HSV-IL-2 To determine whether any other members of the IL-12 family can alter demyelination, BALB/c mice were injected with IL-23 DNA, IL-27 DNA or IL-35 DNA, either once or three times before ocular infection with HSV-IL-2. Demyelination in the optical nerves, SCs and brains of infected mice was evaluated on day 14 post infection. Demyelination was detected in the optical nerves, SCs and brains of all BALB/c mice injected with IL-23 DNA ( Figure 3 and Table 2 , IL-23) and IL-27 DNA ( Figure 3 and Table 2 , IL-27). In contrast, demyelination was detected in the SC and brain but not optic nerve of one of the mice injected once with IL-35 DNA, whereas after three injections demyelination was only detected in the SC of the injected mice ( Figure 3 and Table 2 IL-35). Thus, our results suggest that IL-35 DNA reduced the severity of demyelination in injected mice, whereas neither IL-23 nor IL-27 blocked HSV-IL-2-induced CNS demyelination in infected mice.
Quantitation of demyelination severity in infected mice
We observed that the severity of the HSV-IL-2-induced demyelination appeared to be greater in the presence of HSV-IFN-g (Figure 1b ) than in the presence of HSV-IL-4 ( Figure 1a) or parental virus. To determine whether more plaques are present in the CNS of HSV-IL-2+HSV-IFN-g-infected mice as compared with HSV-IL-2 alone, HSV-IL-2+HSV-IL-4 or HSV-IL-2+wt HSV-1, we counted the number and size of the observed plaques in the SCs of infected mice. The data are shown as the area of demyelination per total stained sections in Figure 4 . The area of demyelination in HSV-IL-2+wt HSV-1-infected mice was similar to mice that were infected with HSV-IL-2 alone (at a 1:1 ratio) (Figure 4) . Also, the level of demyelination was not increased when mice were infected with a 100-fold higher dose of wt HSV-1 Role of cytokines in control of CNS demyelination M Zandian et al (ratio of wt to HSV-IL-2¼1:100) ( Figure 4) . However, the area of demyelination in HSV-IL-2+HSV-IL-4-infected mice was significantly lower than mice infected with HSV-IL-2 alone (at a 1:1 ratio) ( Figure 4 ). The level of demyelination was not altered when mice were infected with a 100-fold higher dose of HSV-IL-4 ( Figure 4) . In contrast to coinfection with HSV-IL-4 recombinant virus, the area of demyelination was greater in the CNS of mice coinfected with HSV-IL-2+HSV-IFN-g (at a 1:1 ratio) than in the CNS of mice infected with HSV-IL-2 alone, HSV-IL-2+HSV-IL-4 or HSV-IL-2+wt HSV-1 (Figure 4) . However, the area of demyelination in HSV-IL-2+HSV-IFN-g-infected mice was not increased when mice were infected with a 100-fold higher dose of HSV-IFN-g (ratio of HSV-IFN-g to HSV-IL-2¼1:100). Furthermore, coinfection of HSV-IL-2-infected mice with HSV-IL-12p70 virus reduced severity of demyelination in coinfected mice (at a 1:1 ratio) than in the CNS of mice infected with HSV-IL-2 alone (Figure 4 ), whereas no demyelination was detected in HSV-IL-2+HSV-IL-12p70-infected mice when mice were infected with a 100-fold higher dose of HSV-IL-12p70 ( Figure 4) . Thus, our results suggest that coinfection of HSV-IL-2-infected mice with HSV-IFN-g increases CNS demyelination in a dose-independent manner, IL-4 affects the IL-2-induced demyelination by decreasing its severity and wt HSV-1 does not affect the HSV-IL-2-induced demyelination, neither increasing nor decreasing its severity, whereas HSV-IL-12p70 affects HSV-IL-2-induced demyelination by decreasing its severity in a dose-dependent manner. HSV-IL-2 infection of mice that were injected with IL-12, IL-23, IL-27 or IL-35 DNA also produced different patterns of demyelination ( Figure 3) . We quantitated the area of demyelination (the number and size of observed plaques in the SCs in mice injected either once or three times with each of these cytokine DNAs. As shown in Figure 5 (one injection), mice injected once with either IL-12, IL-23 or IL-35 DNA had significantly smaller areas of demyelination than mice injected with vector control or mice injected with IL-27. A greater area of demyelination was detected in the CNS of mice injected with IL-27 once than other groups ( Figure 5 , one injection). No demyelination was detected in the CNS of mice injected three times with IL-12 DNA, and no changes were detected in the level of demyelination in mice injected three times with either IL-23 or IL-23 ( Figure 5 , three injections). Similarly, a smaller area of demyelination was detected in the CNS of mice injected three times with IL-35 DNA ( Figure 5 ). Thus, our results suggest that injection of mice with IL-27 increased the severity of CNS demyelination, whereas IL-12, IL-23 and IL-35 reduced the severity of CNS demyelination, with IL-12 and IL-35 having a more important role in reducing and eliminating demyelination, respectively. IL-12 reduced the severity of demyelination in a dose-dependent manner, whereas reduction in demyelination in IL-23 and IL-35-injected mice was dose-independent, as was the increase in the severity of demyelination in IL-27 DNA-injected mice.
Our coinfection results with HSV-IL-12p70 and DNA injection with IL-12 DNA, IL-23 DNA and IL-35 DNA showed significant reduction or elimination of HSV-IL-2-induced CNS demyelination in infected mice. As IL-12p35 and/or IL-12p40 are components of IL-12p70, IL-23, IL-27 and IL-35, to determine whether IL-12p35 or IL-12p40 individually or in combination would alter the severity of HSV-IL-2-induced demyelination, mice were coinfected with HSV-IL-2+HSV-IL12p35, HSV-IL-2+HSV-IL12p40 or HSV-IL-2+HSV-IL12p35+HSV-IL-12p40. Similarly, some mice were injected with vector DNA, IL-12p35 DNA, IL-12p40 DNA or IL-12p35+IL-12p40 DNA, and injected mice were ocularly infected with HSV-IL-2. We counted the number and size of the observed plaques in the SCs of infected mice. Figures 1-4 were sectioned, every fourth section was stained, and the size of the demyelination plaques in the entire sections of the SCs was determined, as described in materials and methods. Data are presented as the percentage of the demyelination area in each section per total sections stained using a total of 150 sections from five mice per group. Figure 5 were sectioned, every fourth section was stained, and the size of the demyelination plaques in the entire sections of the SCs was determined, as described in materials and methods. Data are presented as the percentage of the demyelination area in each section per total sections stained using a total of 150 sections from five mice per group.
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The data are shown as the area of demyelination per total stained sections in Figure 6 . The area of demyelination in HSV-IL-2+HSV-IL12p35-, HSV-IL-2+HSV-IL12p40-or HSV-IL-2+HSV-IL-12p35+HSV-IL-12p40-infected mice was similar to mice that were infected with HSV-IL-2 alone ( Figure 6, left panel) . Similarly, no increase in demyelination was observed in mice injected with IL-12p35 DNA, IL-12p40 DNA or IL-12p35+IL-12p40 DNA and infected with HSV-IL-2 compared with vector DNA (not shown). Thus, our results suggest that in contrast to heterodimer forms of IL-12, IL-23 or IL-35, the individual forms of IL-12p35 or IL-12p40 do not affect the HSV-IL-2-induced demyelination, neither increasing nor decreasing its severity.
DISCUSSION
We have reported previously that HSV-IL-2 causes demyelination in periventricular white matter, brain stem and SC white matter-infected mice, whereas wt HSV-1 strain McKrae, HSV-1 strain KOS, parental dLAT2903 or recombinants HSV-1 expressing IL-4 or IFN-g do not. 19, 20 To further confirm the importance of IL-2 in our HSV-IL-2 model of MS, we looked at the possibility of blocking MS-like symptoms in HSV-IL-2-infected mice by coinfection of HSV-IL-2-infected mice with recombinant viruses expressing T H 1 or T H 2 cytokines. The results of these coinfection experiments were then confirmed by injecting mice with plasmid DNAs expressing the genes of interest.
In contrast to IL-2 (refs 9-12), the levels of IL-4 have been reported to be lower than normal in the sera of patients with MS. 37, 31 Recombinant IL-4 has been shown to diminish demyelination and improve the clinical course of mice with EAE, apparently by influencing the development of the T cells to favor protective, rather than harmful, effects. 27 When fed to mice, retinoids, which increase the levels of IL-4 and TGF-a, also improve the course of EAE. 32 It also has been shown that CNS gene therapy with HSV-1 vectors expressing IL-4 protected rhesus monkeys 26 and mice 29, 30 from autoimmune encephalomyelitis, suggesting that vectors containing anti-inflammatory cytokine genes may have a therapeutic potential for MS. Similar to these previous reports, we significantly reduced but could not block HSV-IL-2 CNS demyelination in mice coinfected with HSV-IL-4, independent of the dose of HSV-IL-4 relative to that of HSV-IL-2.
In MS, a clinical trial of recombinant IFN-g was discontinued prematurely because of worsening of disease. 29 Similarly, in this study, we have shown that the CNS demyelination observed in HSV-IL-2-infected mice was exacerbated on coinfection with HSV-IFN-g recombinant virus in a dose-independent manner even though mice infected with HSV-IFN-g recombinant virus alone do not develop CNS demyelination. 19, 20 It has been reported that in EAE induced by CD8 + T cells, administration of anti-IFN-g antibody reduces the severity of the disease, whereas in EAE induced by CD4 + T cells, administration of anti-IFN-g actually aggravates the disease. 33 In our model, both CD4 + and CD8 + T cells contribute to CNS demyelination with CD8 + T cells having a more prominent role then the CD4 + T cells (manuscript in preparation). Thus, the greater demyelination we observed in the presence of HSV-IFN-g recombinant virus could be due in a shift in the T H 1 arm of the immune response in the infected mice.
Previously, we have shown that the infection of mice with HSV-IL-2 induces a T H 1+T H 2 response. 19 IL-12 is known to have a major role in regulating the balance of the T H 1 and T H 2 responses. 34, 35 It has been reported that IL-12 is a critical cytokine in the pathogenesis of EAE, 38 and subsequent studies showed that the IL-12p40 component of IL-12 is involved in EAE-induced CNS pathology; but this effect is mediated by the binding of the IL-12p40 to IL-23p19 rather than its binding to IL-12p35. 39, 40 Thus, an imbalance of IL-12p40 and IL-12p35 in the HSV-IL-2-infected mice may be responsible for a shift to a T H 1+T H 2 pattern of cytokine responses, as we reported previously. 19 Recently, we have shown that HSV-IL-2 infection of macrophages alters the balance of IL-12p35 and IL12p40 transcripts, which could alter the development of the T H 1 response in the HSV-IL-2-infected mice. This possibility is supported by our current results that showed that coinfection of mice with a recombinant HSV-1 expressing IL-12p70 blocked HSV-IL-2-induced demyelination in a dose-dependent manner. At a 1:1 or 1:10 ratio of HSV-IL-2 to HSV-IL-12p70, 80% of the coinfected mice were protected from demyelination, and at a ratio of 1:100, none of the infected mice developed CNS demyelination. Similarly, when mice were injected either once or twice with IL-12p70 DNA and then infected with HSV-IL-2, 80% of the mice were protected from CNS demyelination, whereas 100% of the mice injected three times with IL-12p70 DNA were protected from demyelination. However, coinfection of mice with HSV-IL-2+HSV-IL12p35, HSV-IL-2+IL-12p40 or HSV-IL-2+HSV-IL-12p35+IL-12p40 did not block demyelination. Similarly, injection of IL-12p35 DNA alone, IL-12p40 DNA alone or a mixture did not block demyelination in HSV-IL-2-infected mice.
The IL-12 family members are heterodimeric complexes, composed of an a-subunit (p35, p19 or p28) and a b-subunit (p40 and EpsteinBarr virus-induced gene 3. 41 The p40 subunit covalently binds to the p35 and p19 chains to form IL-12p70 and IL-23, respectively, whereas Epstein-Barr virus-induced gene 3 binds non-covalently to p28 and p35 to form IL-27 and IL-35, respectively. 42 In this study, we have 43 and asthma 44 and that IL-27 neutralization protects mice against lethal septic peritonitis by enhancing the neutrophil function. 45 IL-27 also was shown to inhibit peripheral conversion of T cells into inducible Tregs. 46 The IL-27 inhibitory effect on T H 2 and cytokine production is due to downregulation of GATA-3 and upregulation of T-bet expression. 47 Thus, in contrast to other members of IL-12 family, IL-27 seems to have a negative effect on T H development and cytokine production. Therefore, the higher demyelination in IL-27-injected mice could be due to a shift in T H 1/T H 2 responses. Some studies suggested that the IL-23/T H 17 pathway has a crucial role in the development of autoimmunity. 48 However, our results rule out the involvement of IL-23 in HSV-IL-2-induced demyelination. In this study, we have shown that IL-35 blocks demyelination in optic nerves and brains of HSV-IL-2-infected mice and significantly reduces demyelination in SC (SC) of infected mice. Previously, it was shown that IL-35 displays immunosuppressive properties. 49, 50 The results indicate that (1) the development of the demyelinated lesions observed after infection of mice with HSV-IL-2 is blocked in a dose-dependent manner on coinfection with IL-12p70 recombinant virus or injection of IL-12p70 DNA. Demyelination also was significantly reduced on injection of IL-35 DNA injection; (2) the HSV-IL-2-induced demyelination was reduced by coinfection with recombinant virus expressing IL-4 or injection of IL-23 DNA; (3) the HSV-IL-2-induced demyelination was not altered by coinfection with recombinant viruses expressing IL-12p35, IL-12p40 or both; and (4) the HSV-IL-2-induced demyelination was enhanced by coinfection with IFN-g recombinant virus or injection of IL-27 DNA. In summary, our results suggest a potential role for IL-12p70 and IL-35 in the inhibition of HSV-IL-2-induced immunopathology.
MATERIALS AND METHODS
Mice, viruses and cells
Six-week old female BALB/c or C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Animals were handled in accordance with the ARVO statement for the Use of Animals in Ophthalmic and Vision Research under an approved IACUC protocol.
Plaque-purified HSV-1 strains, McKrae or KOS (wt) and HSV-1 recombinant viruses expressing IL-2, IL-4, IFN-g, IL-12p35, IL-12p40 or IL-12p70 (HSV-IL-2, HSV-IL-4, HSV-IFN-g, HSV-IL-12p35, HSV-IL-12p40 and HSV-IL-12p70) were grown in rabbit skin cell monolayers in minimal essential medium containing 5% fetal calf serum, as described previously. 14, 15, 17 McKrae and HSV-IFN-g viruses are virulent at an infectious dose of 2Â10 5 PFUs per eye, whereas the other viruses used in this study are attenuated. Previously, we have shown that in tissue culture, the replication of the HSV-IL-2 was 2 logs lower than the wt virus at a low multiplicity of infection. 14, 15, 17 Addition of recombinant anti-IL-2 polyclonal antibody markedly enhanced HSV-IL-2 replication in tissue culture. In the 7-day period after ocular infection of BALB/c mice, the replication of HSV-IL-2 was significantly lower than that of wt virus in tear cultures, whole eyes and brain, but was equivalent to wt replication in the trigeminal ganglia.
Ocular infection
Mice were infected ocularly with 2Â10 5 
Preparation of optic nerve, SC and brain for pathologic analysis
The optic nerves, SCs and brains of the experimental and control mice were removed at necropsy on day 14 post infection. They were then snap-frozen in an isopentane-liquid nitrogen bath and stored at -80 1 C. Transverse sections of each tissue, 8-10 mm thick, were cut, air dried overnight, and fixed in acetone for 3 min at 25 1C. 51 Demyelination in each section was confirmed by monitoring adjacent sections.
Analysis of demyelination using LFB staining
The presence or absence of demyelination in the optic nerves, SCs and brains of infected mice was evaluated using LFB staining of formalin-fixed sections, as we described previously. 19 The number, size and shape of plaques on multiple fields were evaluated by investigators, who were blinded to the treatment groups, using serial sections of CNS tissues. The amount of myelin loss in the stained sections of SCs, optic nerves and brains also was measured using an image analysis system coupled to a microscope. The area of demylinated lesion (clear) to the blue (normal) was measured using 150 random sections from brain, SC and optic nerve of each animal. The percentage of myelin loss was calculated by dividing the lesion size into the total area for each section.
DNA injection
The complete open-reading frames (ORFs) for IL-12p70, IL-23, IL-27 and IL-35 (pORF-mIL12, pORF-mIL23, pORF-mIL27, pORF-mIL35) were purchased from InvivoGen (San Diego, CA, USA), whereas the ORFs for IL-12p35 and IL-12p40 were inserted into pVR1055, as we described previously. 52 Plasmid DNAs were purified using a cesium chloride gradient. In each experiment, five mice per group were injected intramuscularly (in the quadriceps) using a 27-gauge needle with 100 mg of cesium chloride-purified DNA in a total volume of 50 ml of phosphate-buffered saline once (4 h before ocular infection), twice (7 days and 4 h before ocular infection) or three times (14 days, 7 days and 4 h before ocular infection). As a negative control, we used mock-treated mice that were similarly injected with vector DNA alone.
Statistical analysis
Fisher's exact tests were performed using the computer program Instat (GraphPad, San Diego, CA, USA) to compare demyelination in infected mice and in control groups. Results were considered statistically significant when the P-value was o0.05.
